University of Saskatchewan

Cancer Research Cluster

New Publication from Xiang Lab in Cell Mol Immunol

"Transgenic 4-1BBL-engineered vaccine stimulates potent Gag-specific therapeutic and long-term immunity via increased priming of CD44+CD62Lhigh IL-7R+ CTLs with up- and downregulation of anti- and pro-apoptosis genes"


Authors: Wang R, Freywald A, Chen Y, Xu J, Tan X, Xiang J.


Cell Mol Immunol. 2015 Jul;12(4):456-65.  PMID: 25195511


 The paper can be accessed here: http://www.ncbi.nlm.nih.gov/pubmed/25195511

Share on Google+